Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Ødegaard Nielsen

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Nordic Journal of Psychiatry|August 14, 2019
Validation of the Danish version of the brief negative symptom scaleJohannes Gehr, Birte Glenthøj, Mette Ødegaard Nielsen
Journal of Psychiatric Research|November 9, 2025
From trauma to treatment: A scoping review of childhood bullying and its role in psychotic disordersMette Ødegaard Nielsen, Rikke Hilker, Bent Rosenbaum
Current Opinion in Psychiatry|January 16, 2026
Treatment trials for negative symptoms in schizophreniaLouise Birkedal Glenthøj, Mette Ødegaard Nielsen, Merete Nordentoft
Psychiatric Services (Washington, D.C.)|November 1, 2024
Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose ReductionAlexander Nøstdal, Rikke Hilker, Jimmi Nielsen, et al.
Ugeskrift for Laeger|May 29, 2024
Niels August Willer Strand, Mette Ødegaard Nielsen, Jimmi Nielsen
BMJ Case Reports|June 24, 2025
Asenapine-induced severe dystonia in a patient with schizophrenia: medication error due to sound-alike drugSanne Wulff, Jimmi Nielsen, Nicolai Pedersen, et al.
Trials|April 17, 2026
Cognitive behavioral therapy for insomnia vs. standard cognitive behavioral therapy for sleep and circadian disturbances in treatment-resistant schizophrenia: study protocol for the randomized controlled trial (COSTS)Jeppe Feigenberg Johansen, Mette Ødegaard Nielsen, Mette Kragh, et al.
Journal of Psychiatric Research|March 13, 2026
Metabolic parameters as a predictor of relapse in patients with schizophrenia undergoing tapering of antipsychoticsSofie Norlin Mølgaard, Alexander Nøstdal, Jimmi Nielsen, et al.
Psychiatry Research. Neuroimaging|November 2, 2018
Associations between cortical thickness and auditory verbal hallucinations in patients with schizophrenia: A systematic reviewGüldas Köse, Kasper Jessen, Bjørn H Ebdrup, et al.
BMC Psychiatry|March 30, 2024
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case seriesSofie Norlin Mølgaard, Mette Ødegaard Nielsen, Kickan Roed, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Nordic Journal of Psychiatry|August 14, 2019
Validation of the Danish version of the brief negative symptom scaleJohannes Gehr, Birte Glenthøj, Mette Ødegaard Nielsen
Journal of Psychiatric Research|November 9, 2025
From trauma to treatment: A scoping review of childhood bullying and its role in psychotic disordersMette Ødegaard Nielsen, Rikke Hilker, Bent Rosenbaum
Current Opinion in Psychiatry|January 16, 2026
Treatment trials for negative symptoms in schizophreniaLouise Birkedal Glenthøj, Mette Ødegaard Nielsen, Merete Nordentoft
Psychiatric Services (Washington, D.C.)|November 1, 2024
Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose ReductionAlexander Nøstdal, Rikke Hilker, Jimmi Nielsen, et al.
Ugeskrift for Laeger|May 29, 2024
Niels August Willer Strand, Mette Ødegaard Nielsen, Jimmi Nielsen
BMJ Case Reports|June 24, 2025
Asenapine-induced severe dystonia in a patient with schizophrenia: medication error due to sound-alike drugSanne Wulff, Jimmi Nielsen, Nicolai Pedersen, et al.
Trials|April 17, 2026
Cognitive behavioral therapy for insomnia vs. standard cognitive behavioral therapy for sleep and circadian disturbances in treatment-resistant schizophrenia: study protocol for the randomized controlled trial (COSTS)Jeppe Feigenberg Johansen, Mette Ødegaard Nielsen, Mette Kragh, et al.
Journal of Psychiatric Research|March 13, 2026
Metabolic parameters as a predictor of relapse in patients with schizophrenia undergoing tapering of antipsychoticsSofie Norlin Mølgaard, Alexander Nøstdal, Jimmi Nielsen, et al.
Psychiatry Research. Neuroimaging|November 2, 2018
Associations between cortical thickness and auditory verbal hallucinations in patients with schizophrenia: A systematic reviewGüldas Köse, Kasper Jessen, Bjørn H Ebdrup, et al.
BMC Psychiatry|March 30, 2024
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case seriesSofie Norlin Mølgaard, Mette Ødegaard Nielsen, Kickan Roed, et al.
Pageof 4